Early R&D foundations
Our founding team began laboratory research on α-Lipoic Acid synthesis, exploring chiral resolution methods and establishing the analytical protocols that would underpin all future development work.
Suzhou Pharmaceutical Technology Co., Ltd.
Dedicated synthesis labs operational
Suzhou Pharmaceutical Technology Co., Ltd. was formally incorporated with its own synthesis laboratories and pilot plant. Initial R&D programs targeted Trilostane and Pimobendan process development, achieving first successful multi-kilogram batches within the year.
Production capacity expansion
Upgraded reactor systems and added new production lines, increasing batch capacity from laboratory scale to multi-ton output. Expanded analytical lab with LC-MS and additional HPLC instruments to support growing product portfolio.
New research programs & process innovation
Launched new R&D programs targeting novel API intermediates and expanded our custom synthesis services. Ongoing investment in process optimization continues to improve yields, reduce solvent use, and shorten cycle times across our core product lines.